Emeron
Non-steroidal anti-inflammatory drug (NSAID) from the sulfonanilide class. It is a selective competitive inhibitor of cyclooxygenase-2 (COX-2), inhibits the synthesis of prostaglandins in the focus of inflammation.
Composition
one tablet contains:
active substance: Nimesulide 100 mg.
excipients: dioctyl sodium sulfosuccinate, hydroxypropyl cellulose, lactose monohydrate, microcrystalline cellulose, povidone, hydrogenated castor oil, magnesium stearate, sodium starch glycolate.
Indications for use
Indications for use:
-rheumatoid arthritis;
-articular syndrome with exacerbation of gout;
-psoriatic arthritis;
– ankylosing spondylitis;
– osteochondrosis with radicular syndrome;
– osteoarthritis;
-myalgia of rheumatic and non-rheumatic genesis;
-inflammation of ligaments, tendons, bursitis, including post-traumatic inflammation of soft tissues;
-pain syndrome of various origins (including in the postoperative period, with injuries, algomenorrhea, toothache, headache, arthralgia, lumboishalgia).
The drug is intended for symptomatic therapy, reducing pain and inflammation at the time of use, does not affect the progression of the disease.
Mode of application
The minimum effective dose should be used in the smallest possible short course. The tablets are taken after meals.
Adults and children over 12 years old (body weight at least 40 kg) 1 tablet 2 times a day. In the presence of diseases of the gastrointestinal tract, it is advisable to take the drug at the end of a meal or after a meal. The maximum daily dose for adults is 200 mg.
Patients with chronic renal failure require a daily dose reduction of up to 100 mg.